Top Markets
#1 Palladium Network Palladium Network +27.90%
#2 Ankr Network Ankr Network +26.55%
#3 BankrCoin BankrCoin +15.90%
#4 Status Status +15.24%
#5 Siren Siren +8.82%
#6 WAX WAX +6.92%
#7 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +6.84%
#8 Wiki Cat Wiki Cat +6.64%
#9 would would +6.14%
#10 Asteroid Shiba Asteroid Shiba +5.16%
Coin of the day
Palladium Network Palladium Network
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Acepodia, Inc. Acepodia, Inc.

Acepodia, Inc.

6976
Rangering i aksjer #17936
Acepodia, Inc. is an advanced-stage biotechnology firm focused on pioneering... Acepodia, Inc. is an advanced-stage biotechnology firm focused on pioneering cell-based treatments. The company utilizes its distinctive Antibody Cell Conjugation (ACC) platform technology to innovate therapeutic approaches and address critical unmet needs in oncology. Through this proprietary method, Acepodia engineers novel ACE therapies by precisely attaching tumor-specific antibodies to its specialized immune cells, such as gamma delta 2 T cells. Established in 2017, the company's corporate headquarters are situated in Grand Cayman, Cayman Islands.
Aksjekurs
$0.37840843
Sist synkronisert: 2026-09-02
Markedsverdi
$219.66M
Endring (1 dag)
-0.42%
Endring (1 år)
-27.31%
Land
KY
Handel Acepodia, Inc. (6976)

Kategori

Healthcare
Inntekter for Acepodia, Inc. (6976)
Inntekter i 2026 TTM: 0
Ifølge Acepodia, Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Acepodia, Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH